PFLL Combined With PD-1 Antibody With or Without FMT for Oligometastatic NPC,a Phase III ,Open, Randomized Clinical Trial.

Clinical trial NCT06486220 · UNKNOWN

Trial details

NCT number: NCT06486220
Sponsor: Yun-fei Xia
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Nasopharyngeal Carcinoma

Start date: 2024-07-01
Primary completion: 2025-07-01
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.